AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $1.07 billion. The enterprise value is $679.55 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 303.16 million shares outstanding. The number of shares has increased by 1.49% in one year.
| Current Share Class | 303.16M |
| Shares Outstanding | 303.16M |
| Shares Change (YoY) | +1.49% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 22.35% |
| Owned by Institutions (%) | 27.67% |
| Float | 207.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.24 |
| Forward PS | 35.28 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.32, with a Debt / Equity ratio of 0.15.
| Current Ratio | 11.32 |
| Quick Ratio | 10.07 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -14.47% and return on invested capital (ROIC) is -36.58%.
| Return on Equity (ROE) | -14.47% |
| Return on Assets (ROA) | -9.99% |
| Return on Invested Capital (ROIC) | -36.58% |
| Return on Capital Employed (ROCE) | -16.80% |
| Weighted Average Cost of Capital (WACC) | 7.96% |
| Revenue Per Employee | $133,680 |
| Profits Per Employee | -$260,520 |
| Employee Count | 562 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -31.18M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.21% in the last 52 weeks. The beta is 0.87, so ABCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +50.21% |
| 50-Day Moving Average | 3.64 |
| 200-Day Moving Average | 4.10 |
| Relative Strength Index (RSI) | 50.87 |
| Average Volume (20 Days) | 3,566,374 |
Short Selling Information
The latest short interest is 51.32 million, so 16.93% of the outstanding shares have been sold short.
| Short Interest | 51.32M |
| Short Previous Month | 50.22M |
| Short % of Shares Out | 16.93% |
| Short % of Float | 24.69% |
| Short Ratio (days to cover) | 12.06 |
Income Statement
In the last 12 months, ABCL had revenue of $75.13 million and -$146.41 million in losses. Loss per share was -$0.49.
| Revenue | 75.13M |
| Gross Profit | -111.70M |
| Operating Income | -217.10M |
| Pretax Income | -177.60M |
| Net Income | -146.41M |
| EBITDA | -194.93M |
| EBIT | -217.10M |
| Loss Per Share | -$0.49 |
Full Income StatementBalance Sheet
The company has $533.83 million in cash and $143.22 million in debt, with a net cash position of $390.61 million or $1.29 per share.
| Cash & Cash Equivalents | 533.83M |
| Total Debt | 143.22M |
| Net Cash | 390.61M |
| Net Cash Per Share | $1.29 |
| Equity (Book Value) | 966.90M |
| Book Value Per Share | 3.22 |
| Working Capital | 663.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$131.30 million and capital expenditures -$42.77 million, giving a free cash flow of -$174.07 million.
| Operating Cash Flow | -131.30M |
| Capital Expenditures | -42.77M |
| Free Cash Flow | -174.07M |
| FCF Per Share | -$0.57 |
Full Cash Flow StatementMargins
Gross margin is -148.68%, with operating and profit margins of -288.98% and -194.88%.
| Gross Margin | -148.68% |
| Operating Margin | -288.98% |
| Pretax Margin | -236.39% |
| Profit Margin | -194.88% |
| EBITDA Margin | -259.47% |
| EBIT Margin | -288.98% |
| FCF Margin | n/a |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.49% |
| Shareholder Yield | -1.49% |
| Earnings Yield | -13.68% |
| FCF Yield | -16.27% |
Analyst Forecast
The average price target for ABCL is $7.75, which is 119.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.75 |
| Price Target Difference | 119.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 9.81% |
| EPS Growth Forecast (5Y) | 4.54% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 1.73 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.73 |
| Piotroski F-Score | 4 |
